Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 60,500 shares at $15.69 ($949K) on 2025-07-09, disclosed to the SEC on 2025-07-10.
Open-market sale of $949k KALV by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.69 | 30,250 | $475K | 50.0% |
| 2 | $15.69 | 30,250 | $475K | 50.0% |
| Total | $15.69 avg | 60,500 | $949K | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |